Nighttime vagal cardiac control and plasma fibrinogen levels in a population of working men and women

Annals of Noninvasive Electrocardiology

Volumn 14, Issue 2, 2009, Pages 176-184

  Von Känel, Roland ^a   Thayer, Julian F ^b,c   Fischer, Joachim E ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Atherosclerosis; Coronary artery disease; Fibrinogen; Heart rate variability

Indexed keywords

FIBRINOGEN;

ADOLESCENT; ADULT; AIRCRAFT; ARTICLE; BLOOD ANALYSIS; FEMALE; FIBRINOGEN BLOOD LEVEL; GERMANY; HEART RATE; HUMAN; LIFESTYLE; MALE; MEDICAL EXAMINATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY, AMBULATORY; EMPLOYMENT; FEMALE; FIBRINOGEN; GERMANY; HEART RATE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; SEX DISTRIBUTION; VAGUS NERVE; YOUNG ADULT;

EID: 64949199123     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2009.00293.x     Document Type: Article

References (38)

1. Koenig W. Fibrin(ogen) in cardiovascular disease: An update. Thromb Haemost 2003 89 : 601 609.
2. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis. JAMA 2005 294 : 1799 1809.
3. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 1998 279 : 1477 1482.
4. Schaan BD, Portal VL, de Ugarte MT, et al. Emerging risk factors and early atherosclerosis indices in subjects with impaired glucose tolerance. Diabetes Metab 2005 31 : 581 587.
5. Papanicolaou DA, Wilder RL, Manolagas SC, et al. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998 128 : 127 137.
6. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990 265 : 621 636.
7. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999 340 : 115 126.
8. Dvorak HF, Senger DR, Dvorak AM, et al. Regulation of extravascular coagulation by microvascular permeability. Science 1985 227 : 1059 1061.
9. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001 167 : 2887 2894.
10. Tracey KJ. The inflammatory reflex. Nature 2002 420 : 853 859.
11. Tracey KJ. Physiology and immunology of the cholinergic anti-inflammatory pathway. J Clin Invest 2007 117 : 289 296.
12. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 1996 93 : 1043 1065.
13. Sloan RP, McCreath H, Tracey KJ, et al. RR interval variability is inversely related to inflammatory markers: The CARDIA study. Mol Med 2007 13 : 178 184.
14. von Känel R, Nelesen RA, Mills PJ, et al. Relationship between heart rate variability, interleukin-6, and soluble tissue factor in healthy subjects. Brain Behav Immun 2008 22 : 461 468.
15. Aronson D, Mittleman MA, Burger AJ. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 2001 12 : 294 300.
16. Chuang KJ, Chan CC, Su TC, et al. The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults. Am J Respir Crit Care Med 2007 176 : 370 376.
17. Yue W, Schneider A, Rückerl R, et al. Relationship between electrocardiographic and biochemical variables in coronary artery disease. Int J Cardiol 2007 119 : 185 191.
18. Carney RM, Freedland KE, Stein PK, et al. Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. J Psychosom Res 2007 62 : 463 467.
19. Madsen T, Christensen JH, Toft E, et al. C-reactive protein is associated with heart rate variability. Ann Noninvasive Electrocardiol 2007 12 : 216 222.
20. Eller NH. Total power and high frequency components of heart rate variability and risk factors for atherosclerosis. Auton Neurosci 2007 131 : 123 130.
21. Stein PK, Barzilay JI, Chaves PH, et al. Higher levels of inflammation factors and greater insulin resistance are independently associated with higher heart rate and lower heart rate variability in normoglycemic older individuals: The Cardiovascular Health Study. J Am Geriatr Soc 2008 56 : 315 321.
22. von Känel R, Orth-Gomér K. Autonomic function and prothrombotic activity in women after an acute coronary event. J Womens Health 2008 17 : 1331 1337.
23. Thayer JF, Lane RD. The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychol 2007 74 : 224 242.
24. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957 17 : 237 246.
25. Papoulis A. Probability and statistics. Prentence-Hall International Editions, 1990.
26. Babyak MA. What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004 66 : 411 421.
27. Meade TW, Brozović M, Chakrabarth R, et al. An epidemiological study of the haemostatic and other effects of oral contraceptives. Br J Haematol 1976 34 : 353 364.
28. Vorster HH. Fibrinogen and women's health. Thromb Res 1999 95 : 137 154.
29. Oke SL, Tracey KJ. The inflammatory reflex and the role of complementary and alternative medical therapies. Ann N Y Acad Sci (in press).
30. el-Sayed MS, Sale C, Jones PG, et al. Blood hemostasis in exercise and training. Med Sci Sports Exerc 2000 32 : 918 925.
31. Witek-Janusek L, Albuquerque K, Chroniak KR, et al. Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun 2008 22 : 969 981.
32. von Känel R, Dimsdale JE. Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 2003 124 : 1956 1967.
33. Spencer CP, Godsland IF, Stevenson JC. Is there a menopausal metabolic syndrome? Gynecol Endocrinol 1997 11 : 341 355.
34. Itakura H, Sobel BE, Boothroyd D, et al. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina? Am Heart J 2007 154 : 1059 1064.
35. van Boven AJ, Brouwer J, Crijns HJ, et al. Differential autonomic mechanisms underlying early morning and daytime transient myocardial ischemia in patients with stable coronary artery disease. Br Heart J 1995 73 : 134 138.
36. Rudnicka AR, Rumley A, Lowe GD, et al. Diurnal, seasonal, and blood processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 2007 115 : 996 1003.
37. Muller JE. Circadian variation and triggering of acute coronary events. Am Heart J 1999 137 : S1 S8.
38. Feng DL, Tofler GH. Diurnal physiologic processes and circadian variation of acute myocardial infarction. J Cardiovasc Risk 1995 2 : 494 498.